CAH vs SERA · P/E 35, rev $254.25B vs rev $44.0K
Cardinal Health Inc (CAH) versus Sera Prognostics Inc (SERA) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Sera Prognostics Inc (SERA) is a medical devices company listed on US.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported SERA revenue for 2026-06-30 was $44.0K. Net income was -$17.5M. SERA currently screens at market cap $89.1M.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. SERA currently screens at market cap $89.1M.
Not investment advice. Open the CAH and SERA stock pages for the full models.
Not investment advice.